These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 8863571

  • 21. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL.
    Garzotto M, Hudson RG, Peters L, Hsieh YC, Barrera E, Mori M, Beer TM, Klein T.
    Cancer; 2003 Oct 01; 98(7):1417-22. PubMed ID: 14508828
    [Abstract] [Full Text] [Related]

  • 22. Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings.
    Inahara M, Suzuki H, Kojima S, Komiya A, Fukasawa S, Imamoto T, Naya Y, Ichikawa T.
    Urology; 2006 Oct 01; 68(4):815-9. PubMed ID: 17070359
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.
    Catalona WJ, Richie JP, deKernion JB, Ahmann FR, Ratliff TL, Dalkin BL, Kavoussi LR, MacFarlane MT, Southwick PC.
    J Urol; 1994 Dec 01; 152(6 Pt 1):2031-6. PubMed ID: 7525994
    [Abstract] [Full Text] [Related]

  • 27. Utility of free prostate specific antigen serum level and its related parameters in the diagnosis of prostate cancer.
    Haroun AA, Hadidy AS, Awwad ZM, Nimri CF, Mahafza WS, Tarawneh ES.
    Saudi J Kidney Dis Transpl; 2011 Mar 01; 22(2):291-7. PubMed ID: 21422628
    [Abstract] [Full Text] [Related]

  • 28. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL.
    Bozeman CB, Carver BS, Caldito G, Venable DD, Eastham JA.
    Urology; 2005 Oct 01; 66(4):803-7. PubMed ID: 16230142
    [Abstract] [Full Text] [Related]

  • 29. [Value of determining prostate-specific antigen for early detection or prostatic carcinoma].
    Hammerer P, Huland H.
    Urologe A; 1995 Jul 01; 34(4):283-9. PubMed ID: 7545842
    [Abstract] [Full Text] [Related]

  • 30. Prostate specific antigen density can help avoid unnecessary prostate biopsies at prostate specific antigen range of 4-10 ng/ml.
    Lodeta B, Benko G, Car S, Filipan Z, Stajcar D, Dujmović T.
    Acta Clin Croat; 2009 Jun 01; 48(2):153-5. PubMed ID: 19928413
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations.
    Presti JC, Hovey R, Bhargava V, Carroll PR, Shinohara K.
    J Urol; 1997 Mar 01; 157(3):907-11; discussion 911-2. PubMed ID: 9072597
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: comparison to prostatic biopsy.
    Murray NP, Reyes E, Tapia P, Orellana N, Dueñas R, Fuentealba C, Badinez L.
    Arch Esp Urol; 2011 Dec 01; 64(10):961-71. PubMed ID: 22228894
    [Abstract] [Full Text] [Related]

  • 36. Prospective evaluation of prostate specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate specific antigen levels.
    Arai Y, Maeda H, Ishitoya S, Okubo K, Okada T, Aoki Y.
    J Urol; 1997 Sep 01; 158(3 Pt 1):861-4. PubMed ID: 9258099
    [Abstract] [Full Text] [Related]

  • 37. Longitudinal evaluation of prostate-specific antigen levels in a case-control study.
    De Biasi F, Londero D, Praturlon S, Di Donna A, Feruglio GA, Guerra UP.
    Eur Urol; 1996 Sep 01; 29(2):184-8. PubMed ID: 8647144
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.
    Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM.
    N Engl J Med; 2003 Jul 24; 349(4):335-42. PubMed ID: 12878740
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.